IQVIA Joins Forces with FDA to Improve Understanding of COVID-19’s Community Impact

IQVIA announced a scientific partnership with the U.S. Food and Drug Administration that will serve to provide timely analytics from IQVIA’s CARE Project COVID-19 registry. The project aims to improve understanding of how people in the community are affected by exposure to COVID-19. IQVIA’s research project shows what symptoms are experienced by the infected, the length and severity of those symptoms, and whether the severity of their symptoms are improved by any medications or vitamin supplements they are taking. Find out more about the CARE Project here.

(Source: IQVIA)